PTPA and cancer: Moreover, reduced PP2A activity due to PPP2R2C dysfunction hyperactivates survival pathways, such as PI3K/AKT and MAPK/ERK, further enabling cancer cells to evade apoptosis and enhance survival therapeutic stress [249].